Nicholas Buffinger, PhD
As Vice President, Corporate Development and IP Strategy, Nick drives the company’s operations strategy, managing Surface’s legal, intellectual property, finance and operations functions. Nick brings more than 20 years of life sciences industry experience to Surface.
Nick previously served as Senior Director of Corporate Development and Program Management for CoStim Pharmaceuticals. He was instrumental in CoStim’s corporate development and operations strategy, leading into the company’s acquisition by Novartis in February 2014. Prior to CoStim, Nick was the Director of Strategic Alliances at Novartis Institutes for Biomedical Research, where he drove execution of the biologics technology acquisition strategy. Previous positions include Patent Counsel at Dyax, Associate at Morrison & Forrester, LLP and Manager of Intellectual Property at Celtrix Pharmaceuticals.
Nick has a PhD in cancer biology from Stanford University School of Medicine and a JD from the Santa Clara University of Law.